Profile cover photo
Profile photo
RiverVest Venture Partners
5 followers -
RiverVest invests venture capital in life science innovations with a focus on biopharmaceutical and medical device opportunities.
RiverVest invests venture capital in life science innovations with a focus on biopharmaceutical and medical device opportunities.

5 followers
About
Posts

Post has attachment
We were honored to receive the "Investor of the Year" award at the St. Louis Business Journal inaugural Startup Exit Awards. Nakul Tandon, Tom Melzer and Curtis Rother accept the award on behalf of the entire RiverVest team.
Photo
Add a comment...

Post has attachment
RiverVest's Karen Spilizewski to serve on the international panel of judges at the Biomedical Innovation Cup #VC #Biotechnology https://lnkd.in/d9jujx4
Add a comment...

Post has attachment
Congratulations to Ciara Kennedy, PhD, CEO of RiverVest portfolio company Amplyx, for winning the Outstanding Individual in Life Science award at Athena San Diego's award ceremony last night. #womeinmedicine #womeninstem
Photo
Add a comment...

Post has attachment
RiverVest portfolio co. Lyric Pharma granted FDA fast track designation for a novel drug to treat a common ICU condition. CMO to present ASPEN http://ow.ly/brYK30hRGOe
Add a comment...

Post has attachment
RiverVest participated in $100 million Series B for Allakos, a biopharma co. developing antibodies for the treatment of allergic, inflammatory and proliferative diseases. http://ow.ly/qRlT30hHczl
Add a comment...

Post has attachment
RiverVest portfolio company Tryton Medical announces new CEO and president, Carl St. Bernard: “We are dedicated to creating unique solutions for patients with significant unmet cardiovascular need.” http://ow.ly/TT8c30hyMGC
Photo
Add a comment...

Post has attachment
We added two medical research pioneers to our advisory board, and our portfolio companies have been busy: Allakos secured $100M in funding, Amplyx raised $67M for new anti-fungal drug, Tryton Medical received FDA approval for its side branch stent, and more from our fall/winter news http://ow.ly/wqR130hxCba
RiverVest News
RiverVest News
myemail.constantcontact.com
Add a comment...

Post has attachment
RiverVest portfolio co. Spruce Biosciences receives FDA Orphan Drug Designation for its therapy to treat a rare endocrine disease #VC #biotech http://ow.ly/WScY30h37m5
Add a comment...

Post has attachment
Add a comment...

Post has attachment
Add a comment...
Wait while more posts are being loaded